Atrial Fibrillation
Conditions
Brief summary
The aim of this study is to analyse blood pressure during rate control therapy in patients with tachycardic atrial fibrillation in a real-world emergency cohort.
Detailed description
Atrial fibrillation (AF) is the primary clinical problem in 3.3% to 10.0 % emergency department (ED) admissions. Rate control is an integral part of the management of symptomatic tachycardic AF patients. According to the recent guidelines beta-blockers, digoxin, the calcium channel blockers diltiazem and verapamil, amiodarone or combination therapy should be considered for rate control. Haemodynamic side-effects in particular hypotension may occur. Heart rate and blood pressure behavior in an ED population during rate control therapy in patients with tachycardic atrial fibrillation will be analysed.
Interventions
OTHERRate control
Rate control according to the Atrial fibrillation - ESC Guidelines 2016
Sponsors
Medical University of Vienna
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to 120 Years
Healthy volunteers
No
Inclusion criteria
* Age \> 18 years * Atrial fibrillation or atrial flutter and heart rate ≥ 110 bpm * Indication for rate control * Informed consent
Exclusion criteria
• Inclusion criteria not met
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Mean and maximum blood pressure difference between before (baseline) and during/after medication. | 20th July 2019 to 20th July 2021 |
Contacts
Primary ContactJan Niederdöckl, Dr.med.univ
Backup ContactFilippo Cacioppo
Outcome results
None listed